389 related articles for article (PubMed ID: 16051967)
1. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
[TBL] [Abstract][Full Text] [Related]
2. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
[TBL] [Abstract][Full Text] [Related]
3. Changing cancer outcome: the role of LSUMC Minority-Based Clinical Community Oncology Program.
Hayden J; Veith R; Thomas SM; Austin JP; Moore T
J La State Med Soc; 1997 Apr; 149(4):131-3. PubMed ID: 9130816
[TBL] [Abstract][Full Text] [Related]
4. HIV/AIDS: a minority health issue.
Cargill VA; Stone VE
Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
[TBL] [Abstract][Full Text] [Related]
5. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
[TBL] [Abstract][Full Text] [Related]
6. Ecological analysis of the first generation of community clinical oncology programs.
Schopler JH
Health Serv Res; 1993 Apr; 28(1):69-95. PubMed ID: 8463110
[TBL] [Abstract][Full Text] [Related]
7. Adapting clinical trials networks to promote cancer prevention and control research.
Weiner BJ; McKinney MM; Carpenter WR
Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
[TBL] [Abstract][Full Text] [Related]
8. Organizations and structures that facilitate community research.
Coltman CA
Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
[TBL] [Abstract][Full Text] [Related]
9. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities among clinical research investigators.
Getz K; Faden L
Am J Ther; 2008; 15(1):3-11. PubMed ID: 18223347
[TBL] [Abstract][Full Text] [Related]
11. Interorganizational exchanges as performance markers in a community cancer network.
McKinney MM; Morrissey JP; Kaluzny AD
Health Serv Res; 1993 Oct; 28(4):459-78. PubMed ID: 8407338
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer care at a community-based teaching hospital.
Witt RL; Frelick RW
Head Neck; 2005 Jul; 27(7):613-5. PubMed ID: 15825202
[TBL] [Abstract][Full Text] [Related]
13. The effects of managed care and competition on community-based clinical research.
Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
[TBL] [Abstract][Full Text] [Related]
14. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
Joseph G; Dohan D
Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
[TBL] [Abstract][Full Text] [Related]
15. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
16. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
17. Recruiting minority primary care practices into practice-based research.
Hudson SV; Harris-Haywood S; Stange KC; Orzano AJ; Crabtree BF
Med Care; 2006 Jul; 44(7):696-700. PubMed ID: 16799365
[TBL] [Abstract][Full Text] [Related]
18. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000).
Oddone EZ; Olsen MK; Lindquist JH; Orr M; Horner R; Reda D; Lavori P; Johnson G; Collins J; Feussner JR
Control Clin Trials; 2004 Aug; 25(4):378-87. PubMed ID: 15296812
[TBL] [Abstract][Full Text] [Related]
19. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
20. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
Klabunde C; Kaluzny A; Ford L
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
